Comparing the efficacy of intralesional triamcinolone acetonide and hyaluronidase with placental extract in oral submucous fibrosis cases: An original research
Keywords:
hyaluronidase injection, oral submucous fibrosis, placental extract injection, triamcinolone acetonide, trismusAbstract
Intralesional infiltrations with placental extract and triamcinolone with hyaluronidase are equally effective in treating trismus of OSMF. No difference in treatment efficacy was seen in placental extract group or with triamcinolone with hyaluronidase group. Oral submucous fibrosis is a widely prevalent oral mucosal lesion in Indian population and considering its premalignant potential and severe clinical manifestations many studies are done by many authors regarding various aspects of this condition such as etiology pathogenesis and treatment. Arecoline of Areca catechu is mostly attributed as the causative factors in addition to pan and tobacco in different combinations. In our study a random allocation of 120 patients was done equally into two groups. Group 1 received 4 ml of placental extract injection intralesionally at weekly interval for 12 weeks and Group 2 received combination of triamcinolone acetonide( 10 mg/ml) + hyaluronidase (1,500 IU) at weekly intervals for 12 weeks. Treatment outcome was evaluated on the basis of improvement in trismus, oral mucosal pattern and reduction in burning sensation.
Downloads
References
Prabhu, N.; Rao, S.S.; Kotrashetti, S.M.; Baliga, S.D.; Hallikerimath, S.R.; Angadi, P.V.; Issrani, R. Pentoxifylline in patients with oral submucous fibrosis-a randomized clinical trial. J. Maxillofac. Oral Surg. 2015, 14, 81–89. [CrossRef] [PubMed]
Veedu, R.A.; Balan, A. A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2015, 120, 588–593. [CrossRef] [PubMed]
Slade, G.D. Derivation and validation of a short-form oral health impact profile. Community Dent. Oral. Epidemiol. 1997, 25,284–290. [CrossRef]
Ffrooz, A.; Tehranchia-Nia, Z.; Ahmed, A. Benefits and risks of intralesional corticosteroid injection in the treatment of dermatological diseases. Clin. Exp. Dermatol. 1995, 20, 363–370. [CrossRef]
Canniff, J.; Harvey,W. The aetiology of oral submucous fibrosis: The stimulation of collagen synthesis by extracts of areca nut. Int. J. Oral Surg. 1981, 10 (Suppl. S1), 163–167.
Shah, N.; Sharma, P. Role of chewing and smoking habits in the etiology of oral submucous fibrosis (OSF): A case-control study. J. Oral Pathol. Med. 1998, 27, 475–479. [CrossRef]
Mishra, G.; Ranganathan, K. An overview of classification schemes for oral submucous fibrosis. J. Oral Maxillofac. Pathol. 2006, 10, 55–59.
Bhonsle, R.; Murti, P.R.; Pindborg, J.J.; Daftary, D.K.; Mehta, F.S. Focal vascular dilatations and petechiae in oral submucous fibrosis. Eur. J. Oral Sci. 1981, 89, 270–274. [CrossRef] [PubMed]
Canniff, J.; Harvey,W.; Harris, M. Oral submucous fibrosis: Its pathogenesis and management. Br. Dent. J. 1 1986, 160, 429–434. [CrossRef]
Imam, S.Z.; Nawaz, H.; Sepah, Y.J.; Pabaney, A.H.; Ilyas, M.; Ghaffar, S. Use of smokeless tobacco among groups of Pakistani medical students–a cross sectional study. BMC Public Health 2007, 7, 231. [CrossRef]
Mahmood, Z. Smoking and chewing habits of people of Karachi–1981. J. Pak Med. Assoc. 1982, 32, 34–37.
Shear, M.; Lemmer, J.; Dockrat, I. Oral submucous fibrosis in South African Indians: An epidemiological study. South Afr. Med. J. 1967, 32, 41–46.
Van Wyk, C.; Seedat, H.; Phillips, V. Collagen in submucous fibrosis: An electron-microscopic study. J. Oral Pathol. Med. 1990, 19, 182–187. [PubMed]
Bathi, R.J.; Parveen, S.; Burde, K. The role of gutka chewing in oral submucous fibrosis: A case-control study. Quintessence Int. 2009, 40, e19–e25.
Pindborg, J.; Zachariah, J. Frequency of oral submucous fibrosis among 100 South Indians with oral cancer. Bull. World Health Organ. 1965, 32, 750.
Agrawal, A.; Chandel, S.; Singh, N.; Singhal, A. Use of tobacco and oral sub mucous fibrosis in teenagers. J. Dent. Sci. Res. 2012, 3, 1–4.
Shahid, H.; Qadri, M.; Hassan, S. Oral submucous fibrosis; oral health impact profile of patients and its correlation with its clinical grading. Prof. Med. J. 2017, 24, 1719–1726.
Rimal, J.; Shrestha, A. Validation of Nepalese Oral Health Impact Profile14 and Assessment of Its Impact in Patients with Oral Submucous Fibrosis in Nepal. J. Nepal. Health Res. Counc. 2015, 13, 43–49. [PubMed]
Passi, D.; Bhanot, P.; Kacker, D.; Chahal, D.; Atri, M.; Panwar, Y. Oral submucous fibrosis: Newer proposed classification with c Aziz, S.R. Oral submucous fibrosis: Case report and review of diagnosis and treatment. J. Oral Maxillofac. Surg. 2008, 66, 2386–2389. [CrossRef] [PubMed]
Nair, D.R.; Pruthy, R.; Pawar, U.; Chaturvedi, P. Oral cancer: Premalignant conditions and screening—An update. J. Cancer Res.
Therpeutics 2012, 8, 57–66.ritical updates in pathogenesis and management strategies. Natl. J. Maxillofac. Surg. 2017, 8, 89–94. [CrossRef] [PubMed]
Patil, P.G.; Hazarey, V.; Chaudhari, R.; Nimbalkar-Patil, S. A randomized control trial measuring the effectiveness of a mouthexercising device for mucosal burning in oral submucous fibrosis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2016, 122, 713–718.
[CrossRef]
Tanwir, F.; Akhlaq, H. Oral submucous fibrosis: A chronic deliberating disease of oral cavity. Iran. J. Pathol. 2011, 6, 165–172.
Patil, P.; Hazarey, V.; Chaudhari, R.; Nimbalkar-Patil, S. Clinical Efficacy of a Mouth-Exercising Device Adjunct to Local Ointment, Intra-Lesional Injections and Surgical Treatment for Oral Submucous Fibrosis: A Randomized Controlled Trial. Asian Pac. J. Cancer Prev. 2016, 17, 1255–1259. [CrossRef]
Regezi, J.; Sciubba, J.; Jordan, R. Oral Pathology: Clinical Pathologic Correlations; Dolan, J., Ed.; Elsevier: Amsterdam, The Netherlands, 2016.
Khan, S.; Prashanth, S.K.; Rao, P.K.; Chatra, L.; Veena, K.M. Pathogenesis of oral submucous fibrosis. J. Cancer Res. Ther. 2012, 8, 199. [CrossRef]
27.Tsai CH, Yang SF, Chen YJ, et al. Regulation of interleukin-6 expression by arecoline in human buccal mucosal fibroblasts is related to intracellular glutathione levels. Oral Dis 2004 Nov;10(6):360-64.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
